TMC
RPTP

Trellus Management Company’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Trellus Management Company’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-63,500
Closed -$1M – 121
2015
Q2 		$1M Buy
+63,500
New +$771K 1.13% 22

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Trellus Management Company's RPTP Position: Q3 2015 in Review

Trellus Management Company sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2015, closing a stake of 63,500 shares — an estimated $1M sold.

Trellus Management Company first reported a position in RPTP in Q2 2015 and held it in 1 quarter. The position peaked at $1M in Q2 2015. 106 funds tracked by Wall St. Rank hold RPTP as of Q3 2015.

  • Trellus Management Company reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Trellus Management Company sold 63,500 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2015, an estimated $1M.
  • Trellus Management Company first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 1 quarter.
  • Trellus Management Company's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1M in Q2 2015.
  • 106 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2015.

Based on Trellus Management Company's 13F filing for Q3 2015, filed 14 Oct 2015.